Cost-Effectiveness Analysis of Laboratory Monitoring in Newly Diagnosed Telogen Effluvium Patients

    Rhiannon C. Miller, Kaya L Curtis, Sajjad Abedian, Shari R. Lipner
    Studysummary Targeted testing for telogen effluvium patients can save healthcare costs.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Shedding Low Yield Testing for Telogen Effluvium: A Cross-Sectional Study of Laboratory Results from Newly Diagnosed Patients Journal of The American Academy of Dermatology · 2023